Adaptive Polymersome and Micelle Morphologies in Anticancer Nanomedicine: From Design Rationale to Fabrication and Proof-of-Concept Studies

Imke A.B. Pijpers; Loai K.E.A. Abdelmohsen; Yifeng Xia; Shoupeng Cao; David S. Williams; Fenghua Meng; Jan C.M. van Hest; Zhiyuan Zhong

doi:10.1002/adtp.201800068

Adaptive Polymersome and Micelle Morphologies in Anticancer Nanomedicine: From Design Rationale to Fabrication and Proof-of-Concept Studies

Imke A.B. Pijpers, Loai K.E.A. Abdelmohsen, Yifeng Xia, Shoupeng Cao, David S. Williams, Fenghua Meng, Jan C.M. van Hest, Zhiyuan Zhong

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

39 Downloads (Pure)

Abstract

Intrigued and inspired by the intricacy of natural architectures which display various morphologies, researchers seek to develop artificial counterparts in order to replicate, and thereby harness, their function for diverse applications. In particular, well-defined nanoparticles with various morphologies are of great interest for biomedical research. The impact of morphologically discrete nanoparticles upon the development of nanomedicine is significant, gaining increasing attention for its potential to provide a new avenue for the development of future therapeutic technologies. This progress report discusses adaptive morphologies based on block copolymers as platforms for therapeutic and smart drug delivery applications, including design rationale and controlling the morphology of polymeric nanoparticles. The proof-of-concept studies on influence of shapes of nanoparticles on their anticancer effects in vitro and in vivo are addressed.

Original language	English
Article number	1800068
Number of pages	14
Journal	Advanced Therapeutics
Volume	1
Issue number	8
DOIs	https://doi.org/10.1002/adtp.201800068
Publication status	Published - 4 Sept 2018

Bibliographical note

Funding Information:
I.A.B.P. and L.K.E.A.A. have contributed equally to this work. The authors acknowledge support from the National Natural Science Foundation of China (NSFC 51561135010, 51773146, 51633005), the Dutch Ministry of Education, Culture and Science (Gravitation program 024.001.035), NWO-NSFC Advanced Materials (project 792.001.015), the ERC Advanced grant Artisym (694120), and the European Union's Horizon 2020 research and innovation programme Marie Sk?odowska-Curie Innovative Training Networks (ITN) Nanomed, under grant No. 676137 for funding. D.S.W. thanks the Ser Cymru II programme for support; this project received funding from the European Union's Horizon 2020 research and innovation under the Marie Sk?odowska-Curie grant agreement No. 663830.

Publisher Copyright:
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

Keywords

adaptive morphologies
drug delivery
nanomedicine
nanotechnology

Access to Document

10.1002/adtp.201800068

published versionFinal published version, 1.56 MBLicence: TAVERNE

Cite this

@article{306dad2a50eb493795e6c5f3a08a0d3e,

title = "Adaptive Polymersome and Micelle Morphologies in Anticancer Nanomedicine: From Design Rationale to Fabrication and Proof-of-Concept Studies",

abstract = "Intrigued and inspired by the intricacy of natural architectures which display various morphologies, researchers seek to develop artificial counterparts in order to replicate, and thereby harness, their function for diverse applications. In particular, well-defined nanoparticles with various morphologies are of great interest for biomedical research. The impact of morphologically discrete nanoparticles upon the development of nanomedicine is significant, gaining increasing attention for its potential to provide a new avenue for the development of future therapeutic technologies. This progress report discusses adaptive morphologies based on block copolymers as platforms for therapeutic and smart drug delivery applications, including design rationale and controlling the morphology of polymeric nanoparticles. The proof-of-concept studies on influence of shapes of nanoparticles on their anticancer effects in vitro and in vivo are addressed.",

keywords = "adaptive morphologies, drug delivery, nanomedicine, nanotechnology",

author = "Pijpers, {Imke A.B.} and Abdelmohsen, {Loai K.E.A.} and Yifeng Xia and Shoupeng Cao and Williams, {David S.} and Fenghua Meng and {van Hest}, {Jan C.M.} and Zhiyuan Zhong",

note = "Funding Information: I.A.B.P. and L.K.E.A.A. have contributed equally to this work. The authors acknowledge support from the National Natural Science Foundation of China (NSFC 51561135010, 51773146, 51633005), the Dutch Ministry of Education, Culture and Science (Gravitation program 024.001.035), NWO-NSFC Advanced Materials (project 792.001.015), the ERC Advanced grant Artisym (694120), and the European Union's Horizon 2020 research and innovation programme Marie Sk?odowska-Curie Innovative Training Networks (ITN) Nanomed, under grant No. 676137 for funding. D.S.W. thanks the Ser Cymru II programme for support; this project received funding from the European Union's Horizon 2020 research and innovation under the Marie Sk?odowska-Curie grant agreement No. 663830. Publisher Copyright: {\textcopyright} 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim",

year = "2018",

month = sep,

day = "4",

doi = "10.1002/adtp.201800068",

language = "English",

volume = "1",

journal = "Advanced Therapeutics",

issn = "2366-3987",

publisher = "Wiley-VCH Verlag",

number = "8",

}

TY - JOUR

T1 - Adaptive Polymersome and Micelle Morphologies in Anticancer Nanomedicine

T2 - From Design Rationale to Fabrication and Proof-of-Concept Studies

AU - Pijpers, Imke A.B.

AU - Abdelmohsen, Loai K.E.A.

AU - Xia, Yifeng

AU - Cao, Shoupeng

AU - Williams, David S.

AU - Meng, Fenghua

AU - van Hest, Jan C.M.

AU - Zhong, Zhiyuan

N1 - Funding Information: I.A.B.P. and L.K.E.A.A. have contributed equally to this work. The authors acknowledge support from the National Natural Science Foundation of China (NSFC 51561135010, 51773146, 51633005), the Dutch Ministry of Education, Culture and Science (Gravitation program 024.001.035), NWO-NSFC Advanced Materials (project 792.001.015), the ERC Advanced grant Artisym (694120), and the European Union's Horizon 2020 research and innovation programme Marie Sk?odowska-Curie Innovative Training Networks (ITN) Nanomed, under grant No. 676137 for funding. D.S.W. thanks the Ser Cymru II programme for support; this project received funding from the European Union's Horizon 2020 research and innovation under the Marie Sk?odowska-Curie grant agreement No. 663830. Publisher Copyright: © 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

PY - 2018/9/4

Y1 - 2018/9/4

N2 - Intrigued and inspired by the intricacy of natural architectures which display various morphologies, researchers seek to develop artificial counterparts in order to replicate, and thereby harness, their function for diverse applications. In particular, well-defined nanoparticles with various morphologies are of great interest for biomedical research. The impact of morphologically discrete nanoparticles upon the development of nanomedicine is significant, gaining increasing attention for its potential to provide a new avenue for the development of future therapeutic technologies. This progress report discusses adaptive morphologies based on block copolymers as platforms for therapeutic and smart drug delivery applications, including design rationale and controlling the morphology of polymeric nanoparticles. The proof-of-concept studies on influence of shapes of nanoparticles on their anticancer effects in vitro and in vivo are addressed.

AB - Intrigued and inspired by the intricacy of natural architectures which display various morphologies, researchers seek to develop artificial counterparts in order to replicate, and thereby harness, their function for diverse applications. In particular, well-defined nanoparticles with various morphologies are of great interest for biomedical research. The impact of morphologically discrete nanoparticles upon the development of nanomedicine is significant, gaining increasing attention for its potential to provide a new avenue for the development of future therapeutic technologies. This progress report discusses adaptive morphologies based on block copolymers as platforms for therapeutic and smart drug delivery applications, including design rationale and controlling the morphology of polymeric nanoparticles. The proof-of-concept studies on influence of shapes of nanoparticles on their anticancer effects in vitro and in vivo are addressed.

KW - adaptive morphologies

KW - drug delivery

KW - nanomedicine

KW - nanotechnology

UR - http://www.scopus.com/inward/record.url?scp=85079768156&partnerID=8YFLogxK

U2 - 10.1002/adtp.201800068

DO - 10.1002/adtp.201800068

M3 - Article

SN - 2366-3987

VL - 1

JO - Advanced Therapeutics

JF - Advanced Therapeutics

IS - 8

M1 - 1800068

ER -

Adaptive Polymersome and Micelle Morphologies in Anticancer Nanomedicine: From Design Rationale to Fabrication and Proof-of-Concept Studies

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this